Evaluation and comparison of the interaction between alcohol and moclobemide or clomipramine in healthy subjects
- 1 March 1990
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 100 (1) , 40-45
- https://doi.org/10.1007/bf02245787
Abstract
The interaction of clomipramine and moclobemide with alcohol was compared in a double blind parallel groups study in 24 healthy volunteers. Moclobemide was given at the highest recommended therapeutic dose (200 mg t.i.d.) and clomipramine in a subtherapeutic dose (25 mg b.i.d.) because of its poor tolerance in healthy subjects. Psychometric evaluations were performed during a placebo run-in phase; after a 5-day treatment period; assessments were made before, and again 1 h and 4 h after alcohol ingestion. Alcohol doses were pre-determined for each subject in order to produce a blood alcohol concentration of 0.6 g/l 1 h after alcohol intake and this individual alcohol dose was given on test days. The day before alcohol intake tests for autonomic functions were made to assess the anticholinergic effects of the drugs. Alcohol significantly increased body sway, decreased critical flicker fusion frequency, prolonged choice reaction time, impaired copying skills, impaired memory and increased the subjective feelings of satisfaction and tension. Drugs increased the effect of alcohol on body sway and this was essentially due to clomipramine. Clomipramine both without and with alcohol increased body sway, prolonged choice reaction time more than did moclobemide. Clomipramine seemed to diminish alcohol-induced memory impairment in one of the memory tests used. Subjects taking clomipramine had significantly more adverse effects after alcohol ingestion than did subjects of the moclobemide group. In contrast to moclobemide, clomipramine produced a moderate but significant drop in standing systolic blood pressure and a clear inhibition of salivary excretion. It may be concluded that no important psychometric differences occurred between moclobemide and clomipramine with respect to their interaction with alcohol but moclobemide did not show anticholinergic properties and produced fewer adverse effects than clomipramine in interaction with alcohol.This publication has 28 references indexed in Scilit:
- Rediscovering monoamine oxidase inhibitors.BMJ, 1989
- The effects of paroxetine and other antidepressants in combination with alcohol in psychomotor activity related to car drivingHuman Psychopharmacology: Clinical and Experimental, 1988
- A comparative study of the interactions of alcohol with amitriptyline, fluoxetine and placebo in normal subjectsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1987
- Three antidepressants (amitriptyline, dothiepin, fluoxetine), with and without alcohol, compared with placebo on tests of psychomotor ability related to car drivingHuman Psychopharmacology: Clinical and Experimental, 1987
- High urinary norepinephrine excretion in major depressive disorders: effects of a new type of MAO inhibitor (Moclobemide, RO 11-1163)Acta Psychiatrica Scandinavica, 1984
- A Placebo-controlled Study of the Antidepressant Activity of Moclobemide,A New MAO-A InhibitorPharmacopsychiatry, 1984
- Effects of the Tetracyclic Antidepressant Pirlindole on Sensorimotor Performance and Subjective Condition in Comparison to Imipramine and during Interaction of EthanolNeuropsychobiology, 1984
- Amitriptyline and ethanol: Pharmacokinetic and pharmacodynamic interactionEuropean Journal of Clinical Pharmacology, 1983
- Drug Interactions With AlcoholDrugs, 1979
- The action of sedatives on brain stem oculomotor systems in manNeuropharmacology, 1971